EurekAlert!: GLP-1 diabetes drugs likely trump metformin for curbing dementia risk in type 2 diabetes GLP-1 receptor agonists, a class of drug used to treat type 2 diabetes, likely trump the widely prescribed metformin for curbing dementia risk in people with the condition, finds the largest study of ... GLP-1 diabetes drugs likely trump metformin for curbing dementia risk in type 2 diabetes GLP-1 agonists vs metformin: Which diabetes drugs are linked to the lowest dementia risk? Image credit: Maskot/Getty Images “The risk of developing dementia is approximately 1.7 times higher in ...

Context Explanation

ScienceAlert on MSN: Scientists may now know why GLP-1s don't work for 10% of people Drugs like Ozempic are typically administered via injection. (imyskin/Canva) Certain genetic variants, carried by around 10 percent of the population, could be making type 2 diabetes GLP-1 treatments ... Scientists may now know why GLP-1s don't work for 10% of people NPR: Quit a GLP-1? Plan to start again?

Insight Material

It's not recommended, but plenty of people do it